Section Structure
This article is organized to mirror the clinical and policy relevance of the study: highlights, background and unmet need, study design and methods, key findings, interpretation and clinical implications, strengths and limitations, policy relevance, and a concise conclusion with references and funding information.
Highlights
Among Black adults with hypertension receiving care in a Massachusetts-based federally qualified health center (FQHC) network, enrollment in a telehealth navigator intervention with remote patient monitoring (RPM) was associated with a 31.4 percentage point increase in the probability of controlled blood pressure.
The study used a staggered difference-in-differences design with doubly robust ordinary least squares models and inverse propensity weighting, strengthening causal inference in a real-world observational setting.
Primary care visit volume did not increase overall, although event-study analyses suggested a short-term rise in visits during the first 2 months after enrollment, consistent with early care coordination needs.
The findings support telehealth-enabled, equity-focused hypertension management models in safety-net primary care, while also underscoring the need for pragmatic trials, implementation studies, and reimbursement pathways for navigator-based RPM programs.
Background and Unmet Need
Hypertension remains one of the most important modifiable risk factors for myocardial infarction, stroke, heart failure, chronic kidney disease, and premature death. In the United States, Black adults experience a disproportionate burden of hypertension and its complications. These disparities are not explained by biology alone; they reflect structural inequities that shape access to timely diagnosis, longitudinal primary care, medication intensification, home blood pressure monitoring, and coordinated support for social needs.
Federally qualified health centers serve populations that are often medically and socially underserved, making them highly relevant settings for interventions that aim to reduce inequities in cardiovascular outcomes. Yet FQHCs frequently operate under resource constraints, and scalable models that improve hypertension control without substantially increasing in-person visit burden are especially valuable. Telehealth navigation and RPM are attractive options because they can extend outreach, support self-measured blood pressure tracking, improve communication between patients and care teams, and potentially identify barriers such as transportation, unstable housing, medication affordability, or digital literacy.
The present study by Lim, Benjamin, Hategeka, and Cole addresses an important practical question: can a telehealth navigator intervention embedded in an FQHC network improve blood pressure control among Black patients with hypertension in routine care?
Study Design and Methods
Design
This was an observational study using electronic health record data from a Massachusetts-based FQHC network. The investigators applied a staggered difference-in-differences framework, comparing patient outcomes before and after intervention enrollment against outcomes in similar patients who were not yet enrolled or never enrolled during the study period. This design is useful when implementation occurs over time rather than at a single fixed date.
Population
The study cohort included Black adults aged 18 years or older with a baseline diagnosis of hypertension and blood pressure data across multiple study intervals. The intervention group contributed 5,175 person-months and had a mean age of 60 years; 44.3% were female before propensity weighting. The comparison group contributed 328,950 person-months and had a mean age of 57 years; 61.0% were female before weighting.
Intervention
The exposure of interest was enrollment in an FQHC telehealth navigator intervention that provided enhanced care coordination and remote patient monitoring. Although the abstract does not provide a full operational description, the intervention appears to have combined navigator support with home blood pressure monitoring and telehealth-enabled follow-up. In practical terms, such models commonly involve outreach, onboarding to home monitoring, troubleshooting device use, facilitating communication with primary care teams, and helping address missed visits or social barriers.
Outcomes
The primary outcome was controlled blood pressure, defined as less than 140/90 mmHg. This threshold aligns with many quality metrics used in primary care and safety-net settings, although it is less stringent than the blood pressure target recommended for many high-risk adults in contemporary treatment guidelines.
The secondary outcome was total primary care visits, intended to assess whether the program changed healthcare utilization or engagement.
Statistical Approach
The investigators used doubly robust ordinary least squares regression models with inverse propensity weighting. Models adjusted for demographic characteristics, unmet health-related social needs, and clinical diagnoses, with patient-month as the unit of analysis. A doubly robust approach is methodologically appealing because it can yield unbiased estimates if either the outcome model or the propensity model is correctly specified, though not if both are misspecified. Event-study analyses were also performed to examine temporal patterns around enrollment.
Key Findings
Primary Outcome: Blood Pressure Control
The central finding was a strong association between intervention enrollment and improved blood pressure control. The telehealth navigator intervention was associated with a 31.4 percentage point increase in the probability of having controlled blood pressure, with a 95% confidence interval of 13.2 to 49.1 percentage points and a p value of 0.001.
From a clinical standpoint, this is a large effect size. Even allowing for the uncertainty reflected in the confidence interval, the estimate suggests the intervention may have had meaningful impact on cardiovascular risk management in a population with substantial unmet need. In safety-net care, where adherence, access, and continuity challenges often coexist, a change of this magnitude would be highly relevant if replicated.
It is also notable that the study specifically examined Black patients, a population that has historically faced inequitable hypertension outcomes and underrepresentation in implementation research. The intervention therefore addresses both quality improvement and health equity.
Secondary Outcome: Primary Care Engagement
Overall, the intervention did not significantly change total primary care engagement. At first glance, this might seem counterintuitive, because improved blood pressure control is often assumed to require more clinical contact. However, the finding may actually be reassuring. It suggests that better control was not simply driven by a sustained increase in office-based visit volume, but may instead reflect more efficient care coordination, earlier follow-up, and support for self-management through RPM and telehealth navigation.
Event-study analyses provided additional nuance: primary care visits increased significantly during the first 2 months of the intervention. This early rise likely reflects onboarding, medication review, initial troubleshooting of home monitoring, or short-term intensification of clinical management. The absence of a long-term rise in visits may indicate that once systems were established, ongoing management became less resource intensive.
Clinical Interpretation
This study fits within a broader shift from episodic hypertension management toward continuous, team-based care. Home blood pressure monitoring has long been recognized as useful for diagnosis confirmation and treatment titration, and remote monitoring can improve adherence to measurement protocols while reducing therapeutic inertia. Telehealth navigator models may be especially effective when patients face fragmented communication, transportation barriers, or uncertainty about how to act on home readings.
The mechanisms behind the observed benefit are biologically and operationally plausible. More frequent blood pressure measurement can identify uncontrolled hypertension sooner. Navigator contact may improve medication adherence and appointment completion. Care coordination may help clinicians respond more rapidly to trends in home readings. Addressing health-related social needs may also remove practical barriers to sustained blood pressure control.
The result is also important because it was achieved in an FQHC setting rather than an academic hypertension specialty program. That increases its relevance for real-world primary care transformation, particularly in communities where cardiovascular inequities are greatest.
Strengths of the Study
The study has several notable strengths. First, it examines a real-world intervention implemented in routine care, which improves practical relevance. Second, the focus on Black patients directly addresses an equity-critical population that bears disproportionate hypertension morbidity. Third, the staggered difference-in-differences design, combined with inverse propensity weighting and doubly robust modeling, is a thoughtful approach for observational data where randomized assignment is not available. Fourth, incorporation of unmet health-related social needs into adjustment models is particularly appropriate for safety-net populations.
Limitations and Cautions
Despite its strengths, the study remains observational, and residual confounding cannot be excluded. Patients who enrolled in the intervention may have differed from comparison patients in motivation, clinician engagement, access to devices, baseline severity, or unmeasured social factors. Even sophisticated statistical adjustment cannot fully eliminate selection bias.
The abstract does not specify how blood pressure measurements were captured over time, whether home readings were integrated into the outcome assessment, or how missing blood pressure data were handled. In hypertension studies, ascertainment matters: patients with more frequent measurement opportunities can appear to have different control rates simply because they are monitored more closely.
The primary outcome threshold of less than 140/90 mmHg is reasonable for quality reporting but does not capture the more intensive targets often recommended in modern cardiovascular prevention guidelines, particularly for patients with elevated atherosclerotic cardiovascular disease risk. Thus, the study demonstrates improved control by a pragmatic standard, not necessarily optimization to contemporary guideline-preferred targets.
Generalizability is another consideration. The intervention was evaluated within one northeast FQHC network in Massachusetts. Local infrastructure, staffing, digital support, payer mix, and state policy may influence feasibility and effect size. Replication in other regions, including rural systems and under-resourced urban clinics with different patient populations, is needed.
Policy and Practice Implications
The policy implications are substantial. If telehealth navigator programs meaningfully improve hypertension control without requiring sustained increases in in-person visits, they may represent a high-value strategy for primary care systems serving structurally marginalized populations. However, implementation depends on reimbursement. Traditional fee-for-service models do not consistently support navigator outreach, RPM setup, asynchronous blood pressure review, or social-needs-informed coordination.
The authors appropriately note that broader reimbursement for RPM and care models incorporating telehealth navigator roles may be warranted. For policymakers and payers, the key question is whether these programs improve outcomes enough to justify investment. Given the enormous downstream costs of uncontrolled hypertension, even moderate improvements in control rates could be cost-effective, especially in high-risk groups.
For clinicians and healthcare leaders, the study suggests several actionable considerations: identify patients with persistent uncontrolled hypertension; combine home blood pressure devices with active coaching rather than passive distribution; embed navigator or community-health-worker functions within primary care teams; and integrate social needs screening into hypertension workflows. The intervention may be particularly useful during medication titration or after emergency department visits, hospital discharge, or prolonged gaps in care.
How This Fits with Existing Evidence
Current hypertension guidelines endorse out-of-office blood pressure measurement for diagnosis confirmation and ongoing management, and multiple prior studies have supported self-measured blood pressure monitoring, especially when paired with co-interventions such as team-based care or telemonitoring. Evidence also supports team-based models involving nurses, pharmacists, or community health workers. This study extends that literature by focusing on telehealth navigator support in an FQHC population of Black adults and by emphasizing equity-oriented implementation rather than efficacy under tightly controlled trial conditions.
The magnitude of benefit reported here appears larger than in many prior hypertension telemonitoring studies, which raises both interest and caution. It may signal a highly effective, well-targeted intervention in a population with substantial room for improvement, but it also highlights the need for replication, fuller reporting, and ideally prospective evaluation.
Conclusion
This study provides encouraging real-world evidence that a telehealth navigator intervention with remote patient monitoring may substantially improve blood pressure control among Black patients with hypertension receiving care in an FQHC network. The absence of a sustained increase in primary care visit volume suggests that improved outcomes may be achievable through better coordination and self-management support rather than more clinic-intensive care alone.
For clinicians, health system leaders, and policymakers, the message is clear: telehealth-enabled, navigator-supported hypertension management deserves serious consideration as a strategy to reduce cardiovascular inequities. The next step is to confirm effectiveness across diverse settings, clarify which program components drive benefit, assess cost and scalability, and align reimbursement with models that support continuous, equitable chronic disease care.
Funding and ClinicalTrials.gov
The abstract does not report a funding source. No ClinicalTrials.gov registration number is provided in the abstract, which is consistent with the study’s observational design.
References
1. Lim KN, Benjamin EJ, Hategeka C, Cole MB. Impact of a Telehealth Navigator Intervention on Hypertension Control Among Black Patients Served by Federally Qualified Health Centers. Journal of General Internal Medicine. 2026-06-04. PMID: 42243430. Available at: https://pubmed.ncbi.nlm.nih.gov/42243430/
2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71:e13-e115. PMID: 29133356.
3. Muntner P, Shimbo D, Carey RM, et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35-e66. PMID: 30827125.
4. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-Measured Blood Pressure Monitoring in the Management of Hypertension: A Systematic Review and Meta-analysis. Ann Intern Med. 2013;159:185-194. PMID: 23922064.
5. Mills KT, Obst KM, Shen W, et al. Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;168:110-120. PMID: 29255840.
6. Carter BL, Rogers M, Daly J, Zheng S, James PA. The Potency of Team-Based Care Interventions for Hypertension: A Meta-analysis. Arch Intern Med. 2009;169:1748-1755. PMID: 19858437.